Meet the Program Commitee for DIA Japan 2023!

Koji Iwasaki, PhD • Professor, Academic Clinical Research Center,
Osaka University Hospital, Japan

Yukihiro Matsuda, MSc • Director, Clinical Delivery
ICON Clinical Research GK, Japan

Mayu Fujita • Senior Reviewer, Office of Pharmacovigilance l, office of new Drug l
Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Yuko Hata • Associate director, Therapeutic Area Regulatory, Japan Regulatory Affairs
Takeda Pharmaceutical Company, Japan

Yuki Kai, MBA • Clinical Strategy and Resource Management Department, Clinical Development Divis
Chugai Pharmaceutical Co., Ltd.,, Japan

Yusuke Kajimoto • Senior Scientist, Scientific Affairs
MSD K.K., Japan

Keiko Katsui, PhD • Group of Social Co-Creation
Japan Agency for Medical Research and Development (AMED), Japan

Atsushi Kitamura, MS • Director, GCP Quality Japan
Pfizer R&D Japan G.K., Japan

Naoki Kotani, PhD • Pharmaceutical Science Dept.
Chugai Pharmaceutical Co., Ltd., Japan

Kana Maruyama • Manager, Regulatory Labeling, Regulatory Affairs
Viatris Pharmaceuticals Japan GK, Japan

Takeshi Mikami • Sr. Statstical Prgrammer Analysit, SP&A
Janssen: Pharmaceutical Companies of Johnson & Johnson, Japan

Hiroyuki Murakami • Duputy Review Director, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Noriaki Nagao, MPharm, PMP • Pharmaceutical Division,Clinical Development Dept.
JAPAN TOBACCO INC., Japan

Yukiko Nishimura, PhD, MSc • Director
Advocacy Service for Rare and Intractable Diseases, Japan

Katsuhiko Sawada, MPharm • Director, Research and Development Dept.
Otsuka Medical Devices Co.Ltd., Japan

Yasuharu Shibata, MSc • Head of Clinical Data Management, Cliinical Data Management
MSD K.K., Japan

Yoshiyuki Sugimoto, PhD, RPh • Medical Affairs Manager, Medical Affairs, Dermatology, Immunology
Abbvie GK, Japan

Keisuke Suzuki, PhD • Director, Innovation Center for Translational Research
National Center for Geriatrics and Gerontology, Japan

Kazumi Taguchi, MSc • Discovery Accelerator,EIR Business Lead
Astellas Pharma, Japan

Keiko Tsumori, MSc • Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
MSD K.K., Japan

Taiji Yamasaki • Senior Director, Study Management
Merck & Co., Inc., Japan

Motoki Arakawa, PhD • Junior Associate Professor, School of Pharmacy
Nihon University , Japan

Katsuhiko Ichimaru • Review Director, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Mitsuo Ishikawa, MPharm •
Medii, Japan

Jun Yamakami, PhD • Senior Manager, R&D Regulatory 1, Regulatory Affairs
Sanofi K.K., Japan

Haruko Yamamoto, MD, PhD • Executive Director
National Cerebral and Cardiovascular Center, Japan

Junichi Nishino, MSc, RPh • Head, Regulatory Affairs Department
Otsuka Pharmaceutical Co., Ltd., Japan

Goshi Ozawa, MS • Representative Director & President, Japan / R&D Head
Juniper Therapeutix K.K., Japan

Sonoko Misawa, MD, PhD • Associate Professor, Department of Neurology
Chiba University Graduate of Medicine, Japan

Kazuhiko Ishida, MSc, RPh • Director, Pharmacovigilance
Astellas Pharma Inc., Japan

Junko Sato, PhD • Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Soichiro Azumi • Associate Manager, R&D Quality Group
Daiichi Sankyo Co., Ltd., Japan

Koichi GOTO • Deputy Manager
CM Plus Corporation, Japan

Yuiko Kawauchi • Tsukuba Clinical Research & DevelopmentOrganization·Technical Staff
University of Tsukuba Hospital, Japan

Toshifumi Sugizaki • Reviewer, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Shogo Nakamori, MBA, MSc, RPh • Senior Vice President & Managing Director, DIA Japan, Korea, and Singapore
DIA, Japan

Program Committee